Text Size

Executive Function in Learning in Children With Attention Deficit Hyperactivity Disorder (ADHD) Receiving Medical Treatment Alone Compared to Children Receiving Additional Treatment to Improve Learning Strategies

This study is not yet open for participant recruitment.
Verified February 2012 by Hillel Yaffe Medical Center
Sponsor:
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01531127
First received: February 8, 2012
Last updated: February 9, 2012
Last verified: February 2012
History of Changes
  Purpose

The purpose of this study is to determine whether there is a difference in executive function in learning in children with ADHD receiving medical treatment alone to the executive function in children receiving, in addition to medical treatment in learning strategies.


Condition
ADHD

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Level of Executive Functioning [ Time Frame: One year ] [ Designated as safety issue: No ]
    Brief Behavior Rating Inventory of Executive Function will be administered


Estimated Enrollment: 30
Study Start Date: March 2012
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Combined Therapy
ADHD Medication and Learning Strategies Treatment
ADHD Medication Treatment
Control group

  Eligibility

Ages Eligible for Study:   6 Years to 15 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Children with ADHD treated in the Institute for Child Development at Hillel Yaffe Medical Center

Criteria

Inclusion Criteria:

  • Normal development for age
  • ADHD

Exclusion Criteria:

  • Low compliance
  • Developmental delay
  • Chronic disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01531127

Contacts
Contact: Muhammad Mahajnah, MD, PhD 972-506246959 MohamedM@hy.health.gov.il

Locations
Israel
Hillel Yaffe Medical Center
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

No publications provided

Responsible Party: Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01531127     History of Changes
Other Study ID Numbers: 0014-12-HYMC
Study First Received: February 8, 2012
Last Updated: February 9, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders Diagnosed in Childhood
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013